Cargando…

Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?

Detalles Bibliográficos
Autor principal: Hauschild, A.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695706/
https://www.ncbi.nlm.nih.gov/pubmed/19526078
_version_ 1782168225787674624
author Hauschild, A.
author_facet Hauschild, A.
author_sort Hauschild, A.
collection PubMed
description
format Text
id pubmed-2695706
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Multimed Inc.
record_format MEDLINE/PubMed
spelling pubmed-26957062009-06-12 Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations? Hauschild, A. Curr Oncol Guest Editorial Multimed Inc. 2009-05 /pmc/articles/PMC2695706/ /pubmed/19526078 Text en 2009 Multimed Inc.
spellingShingle Guest Editorial
Hauschild, A.
Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
title Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
title_full Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
title_fullStr Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
title_full_unstemmed Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
title_short Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
title_sort adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?
topic Guest Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695706/
https://www.ncbi.nlm.nih.gov/pubmed/19526078
work_keys_str_mv AT hauschilda adjuvantinterferonalfaformelanomanewevidencebasedtreatmentrecommendations